Aspen Aerogels, Inc. (ASPN) stock plummeted 23.58% in after-hours trading on Wednesday following the release of its fourth-quarter 2024 financial results and disappointing first-quarter 2025 guidance.
While the company's Q4 revenue of $123.1 million beat consensus estimates of $120.8 million, and its Q4 EPS of $0.14 also topped expectations of $0.09, the market reacted negatively to its Q1 2025 guidance.
Aspen Aerogels provided a weak Q1 2025 revenue guidance range of $75 million to $95 million, significantly below the consensus estimate of $104.22 million. Additionally, the company's Q1 EPS guidance range of ($0.18) to $0.00 fell short of the consensus estimate of $0.08.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。